Viewing Study NCT07022561


Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2025-12-27 @ 10:03 PM
Study NCT ID: NCT07022561
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-15
First Post: 2025-06-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Social Prescribing for Advancing Resilience in Kids: A Pilot Study of Social Prescribing
Sponsor: University of Ottawa
Organization:

Study Overview

Official Title: Social Prescribing for Advancing Resilience in Kids (SPARK): A Pilot Study of Social Prescribing for Children and Youth Mental Health in Canada
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SPARK
Brief Summary: The goal of this clinical trial is to learn if the Social Prescription (SP) intervention helps improve mental health and wellbeing in youth. It will also assess the feasibility and acceptability of implementing SP in a community setting. The main questions it aims to answer are:

* Is the SP intervention feasible and acceptable for youth, caregivers, and staff?
* Does the SP intervention improve mental health outcomes, reduce stress, and increase wellbeing and social connectedness in youth?

Researchers will compare the Social Prescription (SP) intervention to an education control group to evaluate its effectiveness in improving youth mental health and wellbeing.

Participants will:

* Be randomized to receive either the SP intervention or be placed in an education control group
* Complete wellbeing and mental health questionnaires at the beginning of the study and again after 12 weeks
* Participate in qualitative interviews to share their experiences after participating in SP
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: